Results 51 to 60 of about 4,947,559 (270)

Value of Non-Invasive Fetal Monitoring Techniques in Detection of Fetal Metabolic Acidemia at Birth

open access: yesActa Medica Martiniana, 2013
Objective. Purpose of the study was to evaluate the diagnostic accuracy of fetal pulse oximetry (FPO) and STanalysis of the fetal ECG (STAN) in prediction of fetal acidemia at birth. Methods.
Dokus K   +4 more
doaj   +1 more source

Neonatal outcomes associated with time from a high fetal blood lactate concentration to operative delivery

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2023
Introduction Adjunctive technologies to cardiotocography intend to increase the specificity of the diagnosis of fetal hypoxia. If correctly diagnosed, time to delivery could affect neonatal outcome.
Magnus B. Berge   +5 more
doaj   +1 more source

Approaches to Preventing Intrapartum Fetal Injury

open access: yesFrontiers in Pediatrics, 2022
Electronic fetal monitoring (EFM) was introduced into obstetric practice in 1970 as a test to identify early deterioration of fetal acid-base balance in the expectation that prompt intervention (“rescue”) would reduce neonatal morbidity and mortality ...
Barry S. Schifrin   +5 more
doaj   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography

open access: yesInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2015
The purpose of this chapter is to assist in the use and interpretation of intrapartum cardiotocography (CTG), as well as in the clinical management of specific CTG patterns.
D. Ayres-de-Campos   +2 more
semanticscholar   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Electronic fetal monitoring, cerebral palsy, and caesarean section: assumptions versus evidence

open access: yesBritish medical journal, 2016
Given evidence that cerebral palsy is not reduced by electronic fetal monitoring, Karin Nelson, Thomas Sartwelle, and Dwight Rouse ask why routine monitoring and related litigation continue to contribute to high rates of caesarean ...
K. Nelson, Thomas P. Sartwelle, D. Rouse
semanticscholar   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

DIAGNOSTIC CONFIRMATION OF THE EVALUATION OF THE TRACING OF ELECTRONIC FETAL MONITORING BASED ON PROBABILITY AND THE S/k RATIO OF ENTROPY

open access: yesMomento, 2018
The correct interpretation of the layout of fetal monitoring is a challenge for current clinical; recently a diagnostic methodology based on the theories of probability and entropy, which managed to assess in an objective and reproducible way the layout ...
Yolanda Soracipa   +2 more
doaj   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy